TY - JOUR
T1 - Primary progressive aphasia and the evolving neurology of the language network
AU - Mesulam, M. Marsel
AU - Rogalski, Emily J.
AU - Wieneke, Christina
AU - Hurley, Robert S.
AU - Geula, Changiz
AU - Bigio, Eileen H.
AU - Thompson, Cynthia K.
AU - Weintraub, Sandra
N1 - Funding Information:
The work of the authors is supported by the National Institute on Deafness and Communication Disorders (grants DC008552 to M.‑M.M. and DC01948 to C.K.T.), the NIH National Institute on Aging (grant AG13854 for the Alzheimer Disease Centre to M.‑M.M.), and the NIH National Institute on Neurological Disease and Stroke (grant NS075075 to E.J.R.) Imaging was performed at the Northwestern University Centre for Translational Imaging.
Publisher Copyright:
© 2014 Macmillan Publishers Limited. All rights reserved.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Primary progressive aphasia (PPA) is caused by selective neurodegeneration of the language-dominant cerebral hemisphere; a language deficit initially arises as the only consequential impairment and remains predominant throughout most of the course of the disease. Agrammatic, logopenic and semantic subtypes, each reflecting a characteristic pattern of language impairment and corresponding anatomical distribution of cortical atrophy, represent the most frequent presentations of PPA. Such associations between clinical features and the sites of atrophy have provided new insights into the neurology of fluency, grammar, word retrieval, and word comprehension, and have necessitated modification of concepts related to the functions of the anterior temporal lobe and Wernicke's area. The underlying neuropathology of PPA is, most commonly, frontotemporal lobar degeneration in the agrammatic and semantic forms, and Alzheimer disease (AD) pathology in the logopenic form; the AD pathology often displays atypical and asymmetrical anatomical features consistent with the aphasic phenotype. The PPA syndrome reflects complex interactions between disease-specific neuropathological features and patient-specific vulnerability. A better understanding of these interactions might help us to elucidate the biology of the language network and the principles of selective vulnerability in neurodegenerative diseases. We review these aspects of PPA, focusing on advances in our understanding of the clinical features and neuropathology of PPA and what they have taught us about the neural substrates of the language network.
AB - Primary progressive aphasia (PPA) is caused by selective neurodegeneration of the language-dominant cerebral hemisphere; a language deficit initially arises as the only consequential impairment and remains predominant throughout most of the course of the disease. Agrammatic, logopenic and semantic subtypes, each reflecting a characteristic pattern of language impairment and corresponding anatomical distribution of cortical atrophy, represent the most frequent presentations of PPA. Such associations between clinical features and the sites of atrophy have provided new insights into the neurology of fluency, grammar, word retrieval, and word comprehension, and have necessitated modification of concepts related to the functions of the anterior temporal lobe and Wernicke's area. The underlying neuropathology of PPA is, most commonly, frontotemporal lobar degeneration in the agrammatic and semantic forms, and Alzheimer disease (AD) pathology in the logopenic form; the AD pathology often displays atypical and asymmetrical anatomical features consistent with the aphasic phenotype. The PPA syndrome reflects complex interactions between disease-specific neuropathological features and patient-specific vulnerability. A better understanding of these interactions might help us to elucidate the biology of the language network and the principles of selective vulnerability in neurodegenerative diseases. We review these aspects of PPA, focusing on advances in our understanding of the clinical features and neuropathology of PPA and what they have taught us about the neural substrates of the language network.
UR - http://www.scopus.com/inward/record.url?scp=84926488359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926488359&partnerID=8YFLogxK
U2 - 10.1038/nrneurol.2014.159
DO - 10.1038/nrneurol.2014.159
M3 - Review article
C2 - 25179257
AN - SCOPUS:84926488359
SN - 1759-4758
VL - 10
SP - 554
EP - 569
JO - Nature Clinical Practice Neurology
JF - Nature Clinical Practice Neurology
IS - 10
ER -